RATIONALE: African Americans acutely ill with asthma come to emergency departments more frequently and are admitted to hospital more often than whites but the reasons are unclear. OBJECTIVES: To determine whether such phenomena represent racial differences in attack severity or limited effectiveness of beta(2)-agonist therapy. METHODS AND MAIN RESULTS: We contrasted clinical features, airflow limitation, and albuterol responsiveness in adults acutely ill with asthma, 155 of whom where African American and 140 white, as they presented to eight emergency departments. Assessments were standardized across institutions using a care path, and admission and discharge decisions were made according to predetermined criteria. The degree of obstruction was measured by peak expiratory flow rates. The clinical features of both groups were similar. The African Americans, however, had lower flow rates (p = 0.002), and more of them experienced severe or potentially life threatening episodes (p < 0.001). Albuterol was equally efficacious in both populations and there were no differences in the post-treatment flow rates achieved irrespective of the initial attack intensity. There were no racial differences in admission/discharge ratios. CONCLUSIONS: Our data indicate that African Americans with asthma tend to present with somewhat more intense attacks than whites, but they respond equally well to routine treatment. Similarly, there were no racial disparities in hospitalizations when standard criteria are employed.
RATIONALE: African Americans acutely ill with asthma come to emergency departments more frequently and are admitted to hospital more often than whites but the reasons are unclear. OBJECTIVES: To determine whether such phenomena represent racial differences in attack severity or limited effectiveness of beta(2)-agonist therapy. METHODS AND MAIN RESULTS: We contrasted clinical features, airflow limitation, and albuterol responsiveness in adults acutely ill with asthma, 155 of whom where African American and 140 white, as they presented to eight emergency departments. Assessments were standardized across institutions using a care path, and admission and discharge decisions were made according to predetermined criteria. The degree of obstruction was measured by peak expiratory flow rates. The clinical features of both groups were similar. The African Americans, however, had lower flow rates (p = 0.002), and more of them experienced severe or potentially life threatening episodes (p < 0.001). Albuterol was equally efficacious in both populations and there were no differences in the post-treatment flow rates achieved irrespective of the initial attack intensity. There were no racial differences in admission/discharge ratios. CONCLUSIONS: Our data indicate that African Americans with asthma tend to present with somewhat more intense attacks than whites, but they respond equally well to routine treatment. Similarly, there were no racial disparities in hospitalizations when standard criteria are employed.
Authors: Shweta Choudhry; Pedro C Avila; Sylvette Nazario; Ngim Ung; Jennifer Kho; Jose R Rodriguez-Santana; Jesus Casal; Hui-Ju Tsai; Alfonso Torres; Elad Ziv; Monica Toscano; Jody Senter Sylvia; Mariaelena Alioto; Michael Salazar; Ivan Gomez; Joanne K Fagan; Jorge Salas; Craig Lilly; Henry Matallana; Richard A Castro; Moises Selman; Scott T Weiss; Jean G Ford; Jeffrey M Drazen; William Rodriguez-Cintron; Rocio Chapela; Edwin K Silverman; Esteban González Burchard Journal: Am J Respir Crit Care Med Date: 2005-05-05 Impact factor: 21.405
Authors: E R McFadden; N elSanadi; L Strauss; G Galan; L Dixon; C B McFadden; L Shoemaker; L Gilbert; E Warren; T Hammonds Journal: Am J Med Date: 1997-01 Impact factor: 4.965
Authors: A E Tattersfield; D S Postma; P J Barnes; K Svensson; C A Bauer; P M O'Byrne; C G Löfdahl; R A Pauwels; A Ullman Journal: Am J Respir Crit Care Med Date: 1999-08 Impact factor: 21.405
Authors: L A Lester; S S Rich; M N Blumenthal; A Togias; S Murphy; F Malveaux; M E Miller; G M Dunston; J Solway; R L Wolf; J M Samet; D G Marsh; D A Meyers; C Ober; E R Bleecker Journal: J Allergy Clin Immunol Date: 2001-09 Impact factor: 10.793
Authors: Charlotte Braun-Fahrländer; Josef Riedler; Udo Herz; Waltraud Eder; Marco Waser; Leticia Grize; Soyoun Maisch; David Carr; Florian Gerlach; Albrecht Bufe; Roger P Lauener; Rudolf Schierl; Harald Renz; Dennis Nowak; Erika von Mutius Journal: N Engl J Med Date: 2002-09-19 Impact factor: 91.245
Authors: Michael E Wechsler; Stanley J Szefler; Victor E Ortega; Jacqueline A Pongracic; Vernon Chinchilli; John J Lima; Jerry A Krishnan; Susan J Kunselman; David Mauger; Eugene R Bleecker; Leonard B Bacharier; Avraham Beigelman; Mindy Benson; Kathryn V Blake; Michael D Cabana; Juan-Carlos Cardet; Mario Castro; James F Chmiel; Ronina Covar; Loren Denlinger; Emily DiMango; Anne M Fitzpatrick; Deborah Gentile; Nicole Grossman; Fernando Holguin; Daniel J Jackson; Harsha Kumar; Monica Kraft; Craig F LaForce; Jason Lang; Stephen C Lazarus; Robert F Lemanske; Dayna Long; Njira Lugogo; Fernando Martinez; Deborah A Meyers; Wendy C Moore; James Moy; Edward Naureckas; J Tod Olin; Stephen P Peters; Wanda Phipatanakul; Loretta Que; Hengameh Raissy; Rachel G Robison; Kristie Ross; William Sheehan; Lewis J Smith; Julian Solway; Christine A Sorkness; Lisa Sullivan-Vedder; Sally Wenzel; Steven White; Elliot Israel Journal: N Engl J Med Date: 2019-09-26 Impact factor: 91.245
Authors: Christy Gamble; Evelyn Talbott; Ada Youk; Fernando Holguin; Bruce Pitt; Lori Silveira; Eugene Bleecker; William Busse; William Calhoun; Mario Castro; Kian Fan Chung; Serpil Erzurum; Elliot Israel; Sally Wenzel Journal: J Allergy Clin Immunol Date: 2010-11-04 Impact factor: 10.793
Authors: Ting Wang; Liliana Moreno-Vinasco; Shwu-Fan Ma; Tong Zhou; Yuka Shimizu; Saad Sammani; Yulia Epshtein; D Martin Watterson; Steven M Dudek; Joe G N Garcia Journal: Am J Respir Cell Mol Biol Date: 2014-06 Impact factor: 6.914
Authors: Shwu-Fan Ma; Carlos Flores; Michael S Wade; Steven M Dudek; Dan L Nicolae; Carole Ober; Joe G N Garcia Journal: Genet Epidemiol Date: 2008-12 Impact factor: 2.135
Authors: Candelaria Vergara; Tanda Murray; Nicholas Rafaels; Rachel Lewis; Monica Campbell; Cassandra Foster; Li Gao; Mezbah Faruque; Ricardo Riccio Oliveira; Edgar Carvalho; Maria Ilma Araujo; Alvaro A Cruz; Harold Watson; Dilia Mercado; Jennifer Knight-Madden; Ingo Ruczinski; Georgia Dunston; Jean Ford; Luis Caraballo; Terri H Beaty; Rasika A Mathias; Kathleen C Barnes Journal: Genet Epidemiol Date: 2013-04-02 Impact factor: 2.135
Authors: Carlos Flores; Shwu-Fan Ma; María Pino-Yanes; Michael S Wade; Lina Pérez-Méndez; Rick A Kittles; Deli Wang; Srinivas Papaiahgari; Jean G Ford; Rajesh Kumar; Joe G N Garcia Journal: PLoS One Date: 2012-01-03 Impact factor: 3.240
Authors: Bradley E Chipps; Robert S Zeiger; Alejandro Dorenbaum; Larry Borish; Sally E Wenzel; Dave P Miller; Mary Lou Hayden; Eugene R Bleecker; F Estelle R Simons; Stanley J Szefler; Scott T Weiss; Tmirah Haselkorn Journal: Curr Respir Care Rep Date: 2012-09-20
Authors: Rebecca N Jerome; Jill M Pulley; Nila A Sathe; Shanthi Krishnaswami; Alyssa B Dickerson; Katherine J Worley; Maria F Lima; Consuelo H Wilkins Journal: J Natl Med Assoc Date: 2020-07-28 Impact factor: 1.798